Moderna Inc (NAS:MRNA)
$ 133.79 1.11 (0.8%) Market Cap: 51.27 Bil Enterprise Value: 43.56 Bil PE Ratio: 0 PB Ratio: 4.00 GF Score: 68/100

Moderna Inc at Barclays Global Healthcare Conference (Virtual) Transcript

Mar 11, 2021 / 03:20PM GMT
Release Date Price: $140.47 (+8.26%)
Huidong Wang
Barclays Bank PLC, Research Division - Research Analyst

Good morning, everyone. My name is Gena Wang. I'm SMID cap biotech analyst at Barclays. Welcome to our second virtual global health care conference. First, I wish everyone stay healthy, and I would like to thank all the participants, investors, companies and also especially our event team and the corporate access team, who made this virtual health care conference possible.

With that, it's my great pleasure to introduce Steve Hoge, the President of Moderna. Steve? So maybe I will hand over to you to give a brief overview of the company, and then we will go to a Q&A session.

Stephen Hoge
Moderna, Inc. - President

Terrific. Thank you, Gena, and thank you for having us and for this opportunity. What I'd like to do maybe just to open up is provide a bit of an overview of Moderna more broadly, not just COVID and all of our efforts. Although I expect we'll have a robust conversation about our efforts against COVID-19 as a part of the Q&A.

So as many know, but maybe may

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot